April 9-12 th 2011 7 · 3 Table of contents 1. Introductory word

April 9-12

2011

BelgrAde Summit of Interventional CardiologistS

7th

2

3

Table of contents

1. Introductory word. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2. Annual catheterization laboratories reports for Serbia 2010 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3. Course directors, scientific and organizational commities, international faculty . . . . . . . . . . .

4. Staff involved in data aquisition and patient examination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5. Auspices, endorsment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6. Venue and general Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7. Information on accreditation of the programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8. Event calendar . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9. Programme at-a-glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10. Training courses programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11. Scientific Programme - 7th BelgrAde Summit of Interventional CardiologistS, BASICS + Saturday, April 9, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Sunday, April 10, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Monday, April 11, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Tuesday, April 12, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12. Scientific Programme - Cardiopulmonary exercise testing in focus Friday, April 8, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Saturday, April 9, 2011 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

13. Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4

6

12

14

15

16

18

20

21

22

2525324147

515458

66

4

Dear colleagues,

Upon successful completion of the six BASICS+ (BelgrAde Summit of Interventional CardiologistS): Clinically Integrated Approach, held in Belgrade in 2005-2010, and three CTO mini summits (two of them held in 2008 and one in 2010), with live transmissions of 248 live cases performed on our patients (including among common people even the President of the Serbian Assembly) to the audience of 300 internists/cardiologists, with an excellent success, there is no more dilemma that we simply have to continue the same way and organize an event of the kind on a yearly basis. The success of the previous workshops was complete not only in respect to the care rendered to the patients, but also in respect to education and exchange of experience. Strengthening the old ones and developing new friendships over 3 continents resulted in the third, but not even bit less important dimension of such a meeting. Benevolence and generosity of top international interventional cardiologists to participate as operators, lecturers or commentators, even to bring and donate their PCI tools which are not available in our catheterization laboratories was beyond our expectations, simply to say impressive and unforgettable.The BASICS+ 2011 is recognized and awarded by EBAC (European Board for Accreditations in Cardiology) with 25 hours of external CME credit hours, and we hope that the quality of the BASICS+ will be also continued and recognized in the years to come. For the first time, BASICS+ is accredited by Health Council of Serbia with 13 credits for lecturers and 7 credits for participants. As a continuation of a good established practice, we will organize three training courses: on trans-catheter aortic valve implantation (TAVI), bifurcations and fractional flow reserve measurement.As the key feature of our workshops is clinically integrated approach, we shall continue to present and follow all the patients. By doing so, we are trying to attract and exchange ideas about patients’ well-being with the doctors who are not interventional cardiologists, but are referring patients and are taking care of them post intervention. We will organize symposium “Update Cardiology 2011” compiling lectures about the most important issues of modern cardiology. This year, we go two steps further. First of all, we are organizing a course on ‘CardioPulmonary Exercise Testing’ with complete overview of CPET: from basic physiological principles to application in clinical cardiology. The world recognized experts in that field ( Drs Alessandro Mezzani, Luc Vanhees, Sanja Mazic, Marcus Sandri, Claudio Passino) will unselfishly share their knowledge and experience through their lectures as well as practical sessions.Furthermore, during 7th BASICS+, ‘First symposium of Cardiovascular nursing society of Serbia’ is organized, which is dedicated for nurses and technicians. Needless to say that cardiovascular nurses, as well as nurses in general, are indistinguishable part of interventional team which counts for the full success not just of the procedure, but also in the long term follow up.With Serbia involved in the European “Stent for life” initiative, we are proud to present our latest achievements in obtaining higher rates of reperfusion among STEMI patients. So far, we managed to achieve 711 primary PCIs per million inhabitants in Belgrade, which was our first important target. We have to continue this way and improve reperfusion rates in whole Serbia. Important step forward regarding this issue is the opening of the new cath lab in Health center ‘Valjevo’, and I hope that if this process will continue until the whole Serbia is adequately covered. The support of the President of Serbia, Mr. Boris Tadic, as well as the president of the Board for foreign affairs of the Assembly of Serbia Prof. Dr Dragoljub Micunovic has been of paramount importance. I am also very happy to announce that this year’s BASICS+ will include few more Serbian interventional centers in live cases transmissions that were not involved previously: Clinical hospital center “Zvezdara”, Military medical academy and Health center “Valjevo”. During last year, many important things happened. First of all, new ESC Guidelines on myocardial revascularization were published. I was honored to participate in the Task force 13 that prepared these Guidelines, which is recognition and honor not only for me, but also for the whole Serbian cardiology. During last year, we continued to participate in important interventional studies and registries like STREAM, COMFORTABLE, Kare, C-cure etc. Despite World economic crisis, we managed not only to maintain but also to improve our everyday practice. This would not be possible without the continuous generous support of the course and Scientific Director of the BASICS +Visiting Professor of the Medical School of Belgrade, Dr William Wijns, chairman of the latest ESC/EACTS Guidelines on Myocardial Revascularization and Chairman of PCR. His energy and wisdom have been a great inspiration for all involved in the organization of BASICS+.

5

Miodrag Ostojic, M.D., Ph.D., FESC, FACC, FSCAIProfessor of Cardiology/MedicineAcademician of Serbian Academy of Sciences and ArtsHead, Division of CardiologyClinical Center of SerbiaPresident of the Working group on interventional cardiology,Cardiology Society of SerbiaPresident of the Serbian Heart Foundation

Nothing less could be said for Professor Dr Georgios Sianos, Course director. Also, I would like to express my gratitude to our mentor, friend and teacher Academician Vladimir Kanjuh for his energy devoted to science, clear vision, and continuous support.During the forthcoming BASICS+ we will have sessions on STEMI and STREAM study organized by the Prof. Dr Frans Van de Werf, chairman of the ESC guidelines on STEMI as well as PI of the STREAM. Not less important is the fact that Prof. Dr Stavros Konstantinides will chair the session on Pulmonary embolism and PEITHO study of which he is the PI.With sorrow I have to say that the death of the Emeritus professor Dr Srecko Nedeljkovic, my teacher, mentor and friend, previous Scientific Director of the BASICS + and the death of Dr Aleksandar Doganov, previous Co Director of the BASICS are the great losses not just for us, but the whole medical community. Recent catastrophic earthquake in Japan is a tragic event for the people of Japan. Bearing in mind the diligence and the spirit of Japanese people, I am sure that they will overcome this tragedy. Japanese operators and our traditional BASICS+ Course directors Professors Shigeru Saito and Osamu Katoh are not coming for this BASICS+ and we hope that we will see them on the next BASICS+ to come. It is hard to express our gratitude for all their generosity and unselfish support for all these years. This year, BASICS plus is organized under the auspices of Ministries of health and science of the Republic of Serbia, as well as our traditional patrons TRH Crown Prince Alexander and Princess Katherine.BASICS+ would not be possible without the support of the Departments of Cardiosurgery and vascular surgery and Institute of anesthesiology and reanimathology. We must emphasize the great input and understanding of the School of Medicine, University of Belgrade, their Dean Academician Prof. dr Vladimir Bumbasirevic and the Board of the Dean with Academicians Prof. dr Predrag Pesko, Prof. dr Nebojsa Lalic, Prof. dr Dragan Micic, as well as Prof. dr Slobodan Savic, Prof. dr Tanja Jovanovic and Prof. dr Tatjana Simic.It is of particular importance to note that we had enormous help of the interventional cardiology companies, pharmaceutical industry, ‘Prva srpska televizija’ television, National television, as well as Telekom Srbija Joint Stock Telecommunications Co. and their CEO Branko Radujko, to render live coverage of the event. We could never succeed in organizing this meetings without generous help of “Publishing House for Text Books“ and their CEO Miloljub Albijanic. We do hope that all of them will continue to offer us such a generous support throughout the workshops to follow. Our efforts are generously supported and understood by the Prof. Aleksandar Vuksanovic, CEO of the Fund for the health care of the Republic of Serbia.My special thanks goes to the whole staff of the Division of Cardiology, especially Catheterization laboratories staff, leadership of the Clinical Center of Serbia, CEO Dr Djordje Bajec, Director of Central Pharmacy Office Mr. Ph, V. Ciganovic, Mr V. Kosanovic, Mr D. Bisevac, Mr D. Tanaskovic from the Technical department of Clinical center of Serbia and last but not least to the skeleton of the Workshop’s organization starting with Dr B. Beleslin and Dr M.A. Nedeljkovic. Special thanks goes to “Mladost tourist“ organization, and their CEO Radomir Podinic, as well as to Mr Vojin Varnai, Mr Slobodan Jankovic , Mr Jovan Pavlovic and Mr Bosko Buha. I wish that all our friends, faculty members who devote us their precious time and energy, interventional cardiology companies, pharmaceutical industry, ‘Prva srpska televizija’ television and all participants in the milieu where the border between faculty and attendants is not any longer visible, join us in our mutual endeavor which will certainly result in another successful workshop.We believe that our meeting will further promote knowledge of cardiovascular disease and further stimulate investigation. The previous six BASICS+ and our everyday practice have shown that Serbian Cardiology is ready to be an equal partner in investigational efforts worldwide.

6

Cath-lab reports for 2010 Summary table for institutions equiped with cath-labs in 2010#

Divisionof

Cardiology, Clinical Center of

Serbia

CVInstituteDedinje

Institutefor CVD, Sremska

Kamenica

ClinicalCenter Niš

ClinicalCenter

Kraguje-vac

Military Medical

Academy

Clinicalhospitalcenter

„Bezanij-ska kosa“


„Zemun“


„Zvezdara“

Ukupno

Number of cath labs (N) 2+1* 3 2 2 1** 1+1* 1 1 1 17#

Number of interventional cardiologists/

radiologists (N)

16+4* 10 10 10 3 6+2* 5+1* 7+3* 3+1* 81

Number of doctors in training (N) 8 1 1 2 5 3 1 2 3 26

Dur

ing

wor

king

hou

rs A1: Diagnostic

(N) 2200 4300 3770 1995 500 1532 750 / 937 15984

A2: PCI (N) 2474 1580 1603 590 100 362 337 / 250 7296

A: Total (N) 4674 5880 5373 2585 600 1894 1087 / 1187 23280

Dur

ing

off-

hour

s

B1: Diagnostic (N) 668 50 306 375 772 / 441 / / 2612

B2: PCI (N) 321 20 265 545 486 / 111 / / 1748

B: Total (N) 989 70 571 920 1258 / 552 / / 4360

Total number of diagnostic procedures

(N=A1+B1)2868 4350 4076 2370 1272 1532 1191 2483 937 21079

Total number of PCI (N=A2+B2) 2795 1600 1868 1135 586 362 448 966 250 10010

Total number of coronary procedures

(N=A+B) 5663 5950 5944 3505 1858 1894 1639 3449 1187 31089

Patie

nts t

reat

ed w

ith P

CI

Diabetes (N/%) 360 (13%)

368 (23%)

468 (25%)

207 (18%)

189 (32%)

101 (28%)

112 (25%) / 60

(24%) 1865

(21%) Unstableangina(N/%)

506 (18%)

272 (17%)

414 (22%)

199 (18%)

134 (23%)

82 (23%)

90 (20%) / 73

(29%) 1770

(20%)

NSTEMI(N/%)

68 (2%)

64 (4%)

82 (4%)

118 (10%)

56 (10%)

39 (11%)

45 (10%) / 53

(21%) 525

(6%)

STEMI (N/%) 1340 (48%)

13 (1%)

773 (41%)

375 (33%)

118 (20%)

114 (31%)

137 (31%)

284 (29%)

37 (15%)

3191 (32%)

Prior MI (N/%) 551 (20%)

640 (40%)

585 (31%)

211 (19%)

284 (48%)

184 (51%)

143 (32%) / 100

(40%) 2698

(30%) Prior CABG

(N/%) 78

(3%)176

(11%) 100

(5%)49

(4%)29

(5%)34

(9%)4

(1%) / 13 (5%)

483 (5%)

Multivesseldisease

treated with PCI

(N/%)

1565 (56%)

528 (33%)

638 (34%)

221 (19%)

172 (29%)

118 (33%)

125 (28%) / 58

(23%) 3425

(38%)

Total number of

lesions treated (N)

3214 2620 2421 1475 940 546 708 / 411 12335

7

2

# Patients treated with POBA only

(N/%)

221 (8%)

64 (4%)

121 (6%)

44 (4%)

17 (3%)

18 (5%)

8(2%) / 10

(4%)503

(6%)

# Patients treated with bare metal stents

(N/%)

1541 (55%)

752 (47%)

1079 (58%)

848 (75%)

429 (73%)

301 (83%)

303 (67%) / 135

(54%) 5388

(60%)

# Patients treated with drug eluting

stents (N/%)

422 (15%)

656 (41%)

582 (31%)

204 (18%)

100 (17%)

20 (6%)

93 (21%) / 55

(22%) 2132

(24%)

# Patients treated with combination of bare metal and drug eluting stents (N/%)

611 (22%)

128 (8%)

86 (5%)

39 (3%)

40 (7%)

23 (6%)

44 (10%) / 50

(20%) 1021

(11%)

Total number of bare metal stents (N) 2673 1080 1662 1022 712 488 507 990 266 9400

Total number of drug eluting stents (N) 1202 970 1019 252 144 43 148 325 135 4238

Total number of all stents (N) 3875 2050 2681 1274 856 531 655 1315 401 13638

Number of bare metal stents/patient (N) 1.2 1.2 1.4 1.2 1.5 1.5 1.5 / 1.4 1.3

Number of drug eluting stents/patient

(N)1.2 1.2 1.5 1.0 1.0 1.0 1.1 / 1.3 1.2

Total number of all stents/patient (N) 1.4 1.3 1.4 1.1 1.5 1.5 1.5 1.4 1.6 1.4

Total number of peripheral procedures

(N)2310 2140 148 / / 2298 155 183 211 7445

Diagnostic (N) 1782 86 (1700****) 148 / / 89

(1972****) 147 180 208 6312

Carotid interventions (N) 78 110 0 / / 30 0 2 0 220

Renal interventions (N) 9 43 0 / / 27 0 0 3 82

PTA+stent (N) 406 173 0 / / 158 8 1 10 756 Aortic stent grafts

(N) 35 28 0 / / 22 0 0 0 85

Number of diagnostic electrophysiology

studies15 141 63 / / / / / / 219

Number of RF catheter ablations 256

344+77(CARTO3

RF)40 / / / / / / 717

Total number of invasive

elecrophysiology procedures

271 562 103 / / / / / / 936

* dedicated for peripheral arterial procedures only ** dedicated for both coronary and peripheral arterial procedures *** dedicated for coronary, peripheral arterial procedures and pacemakers **** MDCT # New Cath lab in the Health Center „Valjevo“, started to work on December 22, 2010.

8

COMPA

RISO

NOFTO

TALNUMBE

ROFCO

RONAR

YPR

OCE

DURE

SPE

RFORM

EDIN

SERB

IADURING20

05,200

6,20

07,200

8,20

09AN

D20

10#

Divisionof

Cardiology,

ClinicalCe

nter

ofSerbia*

CVInstitu

teDe

dinje*

Institu

teforC

VD,Sremska

Kamen

ica*

ClinicalCe

nter

Nis*

ClinicalCe

nter

Kragujevac

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

Totalnum

ber

ofdiagno

stic

proced

ures

2536

3310

3247

3546

3215

2868

4100

4111

4042

4455

4310

4350

1619

2830

3440

3710

3892

4076

626

1144

1603

1895

2271

2370

250

521

798

900

1273

1272

Ratio

**

NA

1.31

0.98

1.09

0.91

0.89

NA

1.00

0.98

1.10

0.97

1.00

NA

1.75

1.22

1.08

1.05

1.05

NA

1.83

1.40

1.18

1.20

1.04

NA

2.08

1.53

1.13

1.41

1.00

Totalnum

ber

ofPC

I

710

1662

2186

2101

2585

2795

978

1491

1449

1680

1595

1600

776

930

1265

1512

1834

1868

121

340

548

674

974

1135

50

160

308

368

527

586

Ratio

**

NA

2.34

1.32

0.96

1.23

1.08

NA

1.52

0.97

1.16

0.95

1.00

NA

1.20

1.36

1.20

1.21

1.02

NA

2.81

1.61

1.23

1.45

1.17

NA

3.20

1.93

1.19

1.43

1.11

Totalnum

ber

ofall

coronary

proced

ures

3371

4972

5433

5647

5800

5663

4973

5602

5491

6135

5905

5950

2395

3760

4705

5222

5726

5944

747

1484

2151

2569

3245

3505

300

681

1106

1268

1800

1858

Ratio

**

NA

1.47

1.09

1.04

1.03

0.98

NA

1.13

0.98

1.12

0.96

1.01

NA

1.57

1.25

1.11

1.10

1.04

NA

1.99

1.50

1.19

1.26

1.08

NA

2.27

1.62

1.15

1.42

1.03

STEM

I

42

503

632

799

1000

1340

25

21

21

16

12

13

43

51

373

580

705

773

21

35

88

115

292

375

NA

NA

7

28

75

118

Ratio

**

NA

12.0

1.26

1.26

1.25

1.34

NA

0.84

1.00

0.76

0.75

1.08

NA

1.19

7.31

1.55

1.22

1.10

NA

1.67

2.51

1.31

2.54

1.28

NA

NA

NA

4.0

2.68

1.57

Totalnum

ber

ofbare

metalsten

ts

824

1719

2570

2424

2326

2673

879

1460

1314

1142

1169

1080

1144

1083

1183

1269

1556

1662

108

275

532

567

796

1022

68

161

311

319

581

712

Ratio

**

NA

2.09

1.50

0.94

0.96

1.15

NA

1.66

0.90

0.87

1.02

0.92

NA

0.95

1.09

1.07

1.23

1.07

NA

2.55

1.93

1.07

1.40

1.28

NA

2.37

1.93

1.03

1.82

1.23

Totalnum

ber

ofdrug

elutingsten

ts

180

665

712

873

1030

1202

278

595

705

1145

1270

970

92

445

832

943

1162

1019

36

145

169

273

316

252

2

88

98

169

191

144

Ratio

**

NA

3.69

1.07

1.23

1.18

1.17

NA

2.14

1.18

1.62

1.12

0.76

NA

4.84

1.87

1.13

1.23

0.88

NA

4.03

1.17

1.62

1.16

0.80

NA

44.0

1.11

1.72

1.13

0.75

Totalnum

ber

ofallstents

1004

2384

3282

3297

3356

3875

1157

2055

2019

2287

2439

2050

1236

1528

2015

2212

2718

2681

144

420

701

840

1112

1274

70

249

409

488

772

856

Ratio

**

NA

2.37

1.38

1.00

1.02

1.15

NA

1.78

0.98

1.13

1.07

0.84

NA

1.24

1.32

1.10

1.23

0.99

NA

2.92

1.67

1.20

1.32

1.15

NA

3.56

1.64

1.19

1.58

1.11

*CA

RDIOSU

RGER

YONSITE

**refersto

theratio

ofnu

mbe

rsforthe

year

deno

tedon

thetopof

thecolumnto

thenu

mbe

rsforthe

previous

year

#New

Cath

labintheHe

alth

Center

„Valjevo“,startedto

workon

Decembe

r22,20

10.

9

COMPA

RISO

NOFTO

TALNUMBE

ROFCO

RONAR

YPR

OCE

DURE

SPE

RFORM

EDIN

SERB

IADURING20

05,200

6,20

07,200

8,20

09AN

D20

10#

Divisionof

Cardiology,

ClinicalCe

nter

ofSerbia*

CVInstitu

teDe

dinje*

Institu

teforC

VD,Sremska

Kamen

ica*

ClinicalCe

nter

Nis*

ClinicalCe

nter

Kragujevac

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

Totalnum

ber

ofdiagno

stic

proced

ures

2536

3310

3247

3546

3215

2868

4100

4111

4042

4455

4310

4350

1619

2830

3440

3710

3892

4076

626

1144

1603

1895

2271

2370

250

521

798

900

1273

1272

Ratio

**

NA

1.31

0.98

1.09

0.91

0.89

NA

1.00

0.98

1.10

0.97

1.00

NA

1.75

1.22

1.08

1.05

1.05

NA

1.83

1.40

1.18

1.20

1.04

NA

2.08

1.53

1.13

1.41

1.00

Totalnum

ber

ofPC

I

710

1662

2186

2101

2585

2795

978

1491

1449

1680

1595

1600

776

930

1265

1512

1834

1868

121

340

548

674

974

1135

50

160

308

368

527

586

Ratio

**

NA

2.34

1.32

0.96

1.23

1.08

NA

1.52

0.97

1.16

0.95

1.00

NA

1.20

1.36

1.20

1.21

1.02

NA

2.81

1.61

1.23

1.45

1.17

NA

3.20

1.93

1.19

1.43

1.11

Totalnum

ber

ofall

coronary

proced

ures

3371

4972

5433

5647

5800

5663

4973

5602

5491

6135

5905

5950

2395

3760

4705

5222

5726

5944

747

1484

2151

2569

3245

3505

300

681

1106

1268

1800

1858

Ratio

**

NA

1.47

1.09

1.04

1.03

0.98

NA

1.13

0.98

1.12

0.96

1.01

NA

1.57

1.25

1.11

1.10

1.04

NA

1.99

1.50

1.19

1.26

1.08

NA

2.27

1.62

1.15

1.42

1.03

STEM

I

42

503

632

799

1000

1340

25

21

21

16

12

13

43

51

373

580

705

773

21

35

88

115

292

375

NA

NA

7

28

75

118

Ratio

**

NA

12.0

1.26

1.26

1.25

1.34

NA

0.84

1.00

0.76

0.75

1.08

NA

1.19

7.31

1.55

1.22

1.10

NA

1.67

2.51

1.31

2.54

1.28

NA

NA

NA

4.0

2.68

1.57

Totalnum

ber

ofbare

metalsten

ts

824

1719

2570

2424

2326

2673

879

1460

1314

1142

1169

1080

1144

1083

1183

1269

1556

1662

108

275

532

567

796

1022

68

161

311

319

581

712

Ratio

**

NA

2.09

1.50

0.94

0.96

1.15

NA

1.66

0.90

0.87

1.02

0.92

NA

0.95

1.09

1.07

1.23

1.07

NA

2.55

1.93

1.07

1.40

1.28

NA

2.37

1.93

1.03

1.82

1.23

Totalnum

ber

ofdrug

elutingsten

ts

180

665

712

873

1030

1202

278

595

705

1145

1270

970

92

445

832

943

1162

1019

36

145

169

273

316

252

2

88

98

169

191

144

Ratio

**

NA

3.69

1.07

1.23

1.18

1.17

NA

2.14

1.18

1.62

1.12

0.76

NA

4.84

1.87

1.13

1.23

0.88

NA

4.03

1.17

1.62

1.16

0.80

NA

44.0

1.11

1.72

1.13

0.75

Totalnum

ber

ofallstents

1004

2384

3282

3297

3356

3875

1157

2055

2019

2287

2439

2050

1236

1528

2015

2212

2718

2681

144

420

701

840

1112

1274

70

249

409

488

772

856

Ratio

**

NA

2.37

1.38

1.00

1.02

1.15

NA

1.78

0.98

1.13

1.07

0.84

NA

1.24

1.32

1.10

1.23

0.99

NA

2.92

1.67

1.20

1.32

1.15

NA

3.56

1.64

1.19

1.58

1.11

*CA

RDIOSU

RGER

YONSITE

**refersto

theratio

ofnu

mbe

rsforthe

year

deno

tedon

thetopof

thecolumnto

thenu

mbe

rsforthe

previous

year

#New

Cath

labintheHe

alth

Center


workon

Decembe

r22,20

10.

Military

Med

ical

Acad

emy*

CHC‘Bezan

ijska

kosa’

CHC‘Zem

un’

CHC‘Zvezdara’

Total

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

2005

2006

2007

2008

2009

2010

Totalnum

ber

ofdiagno

stic

proced

ures

1330

1503

1257

1423

1438

1532

NA

836

486

1127

1286

1191

NA

NA

871

1420

1931

2483

NA

NA

NA

610

778

937

10461

14255

15744

19086

20394

21079

Ratio

**

NA

1.13

0.84

1.13

1.01

1.07

NA

NA

0.58

2.32

1.14

0.93

NA

NA

NA

1.63

1.40

1.29

NA

NA

NA

NA

1.28

1.20

NA

1.36

1.10

1.21

1.07

1.03

Totalnum

ber

ofPC

I293

367

354

425

420

362

NA

0

49

306

342

448

NA

NA

236

472

600

966

NA

NA

NA

124

348

250

2928

4950

6395

7662

9225

10010

Ratio

**

NA

1.25

0.96

1.20

0.99

0.86

NA

NA

NA

6.24

1.12

1.31

NA

NA

NA

2.0

1.27

1.61

NA

NA

NA

NA

2.80

0.72

NA

1.69

1.29

1.20

1.20

1.09

Totalnum

ber

ofall

coronary

proced

ures

1623

1870

1611

1848

1858

1894

NA

836

534

1433

1628

1639

NA

NA

1107

1892

2531

3449

NA

NA

NA

734

1126

1187

13409

19205

22139

26748

29619

31089

Ratio

**

NA

1.15

0.86

1.15

1.01

1.02

NA

NA

0.64

2.68

1.14

1.01

NA

NA

NA

1.71

1.34

1.36

NA

NA

NA

NA

1.53

1.05

NA

1.43

1.15

1.21

1.11

1.05

STEM

I

16

10

28

22

151

114

NA

NA

0

76

81

137

NA

NA

12

27

111

284

NA

NA

NA

18

33

37

147

620

1161

1681

2460

3191

Ratio

**

NA

0.63

2.80

0.79

6.86

0.75

NA

NA

NA

NA

1.07

1.69

NA

NA

NA

2.25

4.11

2.56

NA

NA

NA

NA

1.83

1.12

NA

4.22

1.87

1.45

1.46

1.30

Totalnum

ber

ofbare

metalsten

ts

340

472

523

547

493

488

NA

NA

53

265

378

507

NA

NA

282

540

605

990

NA

NA

NA

133

340

266

3363

5170

6768

7206

8244

9400

Ratio

**

NA

1.39

1.12

1.05

0.90

0.99

NA

NA

NA

5.0

1.43

1.34

NA

NA

NA

1.91

1.12

1.64

NA

NA

NA

NA

2.56

0.78

NA

1.54

1.31

1.06

1.14

1.14

Totalnum

ber

ofdrug

elutingsten

ts

40

67

61

97

89

43

NA

NA

8

101

169

148

NA

NA

51

171

232

325

NA

NA

NA

61

120

135

628

2005

2636

3833

4579

4238

Ratio

**

NA

1.68

0.91

1.59

0.92

0.48

NA

NA

NA

12.6

1.67

0.88

NA

NA

NA

3.35

1.36

1.40

NA

NA

NA

NA

1.97

1.13

NA

3.19

1.31

1.45

1.19

0.93

Totalnum

ber

ofallstents

380

539

584

644

582

531

NA

NA

61

366

547

655

NA

NA

333

711

837

1315

NA

NA

NA

194

460

401

3991

7175

9404

11039

12823

13638

Ratio

**

NA

1.42

1.08

1.10

0.90

0.91

NA

NA

NA

6.0

1.49

1.20

NA

NA

NA

2.14

1.18

1.57

NA

NA

NA

NA

2.37

0.87

NA

1.80

1.31

1.17

1.16

1.06

COMPA

RISO

NOFTO

TALNUMBE

ROFCO

RONAR

YPR

OCE

DURE

SPE

RFORM

EDIN

SERB

IADURING20

05,200

6,20

07,200

8,20

09AN

D20

10#(con

t.)

*CA

RDIOSU

RGER

YONSITE

**refersto

theratio

ofnu

mbe

rsforthe

year

deno

tedon

thetopof

thecolumnto

thenu

mbe

rsforthe

previous

year

#New

Cath

labintheHe

alth

Center


workon

Decembe

r22,20

10.

10

11

WO

RKSH

OPS

200

5-20

10. S

UM

MA

RY

Num

ber o

f pts

.N

umbe

r of

CTO

s

Num

ber o

f no

n-C

TO le

-si

ons

succ

es: C

TO

(%)

succ

es: n

on

CTO

(%)

2005

1923

814

(61)

8 (1

00)

2006

3825

1614

(56)

16 (1

00)

2007

4122

2713

(59)

27 (1

00)

2008

4025

2417

(68)

24 (1

00)

Min

i sum

min

t 1

(Sep

200

8)12

152

13 (8

7)2

(100

)

Min

i sum

min

t 2

(Nov

200

8)10

106

9 (9

0)6

(100

)

2009

4625

2518

(72)

25 (1

00)

2010

3017

2315

(88)

23 (1

00)

Min

i sum

mit

3 (A

ug 2

010)

1214

1014

(100

)10

(100

)

Tota

l24

817

614

112

7 (7

2)14

1 (1

00)

12

COURSE DIRECTORSM. Ostojic (Belgrade, Serbia)R. Erbel (Essen, Germany)O. Katoh (Toyohashi, Japan)S. Saito (Kamakura, Japan), Founder of the Belgrade WorkshopG. Sianos (Thessaloniki, Greece)

ORGANIZATIONAL DIRECTORS AND COURSECO-DIRECTORSB.D. Beleslin (Belgrade, Serbia)M.A. Nedeljkovic (Belgrade, Serbia)

COURSE CO-DIRECTORSG. Stankovic (Belgrade, Serbia)S. Stojkovic (Belgrade, Serbia)

BASICS+ DIRECTOR, SCIENTIFIC DIRECTORW. Wijns (Aalst, Belgium)

SCIENTIFIC CO-DIRECTORSV. Kanjuh (Belgrade, Serbia)

SECRETARY GENERALV. Vukcevic (Belgrade, Serbia)

ORGANIZATIONAL AND SCIENTIFICCONSULTANTSJ. Stepanovic (Belgrade, Serbia)A. Djordjevic - Dikic (Belgrade, Serbia)I. Nedeljkovic (Belgrade, Serbia)B. Vujisic-Tesic (Belgrade, Serbia)

INTERNATIONAL GUEST FACULTYR. Bernat (K. Toplice, Croatia)R. Bugiardini (Bologna, Italy)M. Bunc (Ljubljana, Slovenia)B. Clapp (London, United Kingdom)I. Daehnert (Leipzig, Germany)N. Dobrijevic (Banja Luka, RS, BiH)I. Durand Zaleski (Paris, Belgrade)F. Eberli (Zurich, Switzerland)A. Ernst (Zagreb, Croatia)L. Finci (Geneve, Switzerland)A. Galassi (Catania, Italy)O. Goktekin (Eskisehir, Turkey)M. Hamilos (Heraklion, Greece)V. Kanic (Maribor, Slovenia)S. Kedev (Skopje, FYR Macedonia)T. Konorza (Essen, Germany)S. Konstantinides (Alexandroupolis, Greece)M. Krneta (Banja Luka, RS, BiH)A. Lazarevic (Banja Luka, RS, BiH)O. Manfrini (Bologna, Italy)A. Manginas (Athens, Greece)M. Marzilli (Pisa, Italy)E. Merkulov (Moscow, Russia)V. Mitrovic (Bad Nauheim, Germany)

G. Nikolic (Podgorica, Montenegro)V. Nikolic Heitzler (Zagreb, Croatia)M. Noc (Ljubljana, Slovenia)A. G. Osiev (Novosibirsk , Russia)R. Ozdemir (Malatya, Turkey)G. Patti (Rome, Italy)Z. Piroth (Budapest, Hungary)A. Protopopov (Krasnoyarsk, Russia)M. Rabrenovic (Podgorica, Montenegro)S. Srdic (Banja Luka, RS, BiH)K. Stambuk (Zagreb, Croatia)C. Stefanadis (Athens, Greece)M. Strozzi (Zagreb, Croatia)I. Ungi (Szeged, Hungary)F. Van de Werf (Leuven, Belgium)D. Vulic (Banja Luka, RS BIH)D. Zorman (Ljubljana, Slovenia)

SECRETARIESV. Dedovic (Belgrade, Serbia)M. Dobric (Belgrade, Serbia)V. Giga (Belgrade, Serbia)J. Kostic (Belgrade, Serbia)V. Kovacevic (Belgrade, Serbia)Z. Mehmedbegovic (Belgrade, Serbia)D. Milasinovic (Belgrade, Serbia)O. Nedeljkovic (Belgrade, Serbia)I. Paunovic (Belgrade, Serbia)M. Zivkovic (Belgrade, Serbia)

SERBIAN FACULTYS. Aleksandric (Belgrade, Serbia)A. Aleksic (Belgrade, Serbia)Z. Antonic (Belgrade, Serbia)S. Apostolovic (Nis, Serbia)A. Arandjelovic (Belgrade, Serbia)M. Asanin (Belgrade, Serbia)R. Babic (Belgrade, Serbia)B. Beleslin (Belgrade, Serbia)M. Bikicki (S. Kamenica, Serbia )M. Colic (Belgrade, Serbia)D. Debeljacki (S.Kamenica, Serbia)M. Dikic (Belgrade, Serbia)D. Dincic (Belgrade, Serbia)M. Djukic (Belgrade, Serbia)P. Djukic (Belgrade, Serbia)A. Djordjevic Dikic (Belgrade, Serbia)M. Dobric (Belgrade, Serbia)V. Dedovic (Belgrade, Serbia)L. Davidovic (Belgrade, Serbia)V. Giga (Belgrade, Serbia)B. Gligic (Belgrade, Serbia)S. Hinic (Belgrade, Serbia)B. Ilisic (Belgrade, Serbia)V. Ivanovic (S. Kamenica, Serbia)I. Ilic (Belgrade, Serbia)

13

N. Jagic (Kragujevac, Serbia)R. Jung (S.Kamenica, Serbia)I. Jovanovic (Belgrade, Serbia)D. Kalimanovska Ostric (Belgrade, Serbia)D. Kordic (Belgrade, Serbia)D. Kostic (Belgrade, Serbia)A. Kocijancic (Belgrade, Serbia)J. Kostic (Belgrade, Serbia)V. Kovacevic (Belgrade, Serbia)Lj. Mangovski (Belgrade, Serbia)D. Markovic (Belgrade, Serbia)Z. Mehmedbegovic (Belgrade, Serbia)Z. Mijailovic (Belgrade, Serbia)D. Milasinovic (Belgrade, Serbia)G. Milasinovic (Belgrade, Serbia)B. Milosavljevic (Belgrade, Serbia)P. Mitrovic (Belgrade, Serbia)I. Mrdovic (Belgrade, Serbia)S. Mrdja (Belgrade, Serbia)N. Mujovic (Belgrade, Serbia)I. Nedeljkovic (Belgrade, Serbia)I. Nikolajevic (Belgrade, Serbia)N. Ninkovic (Belgrade, Serbia)V. Obradovic (Belgrade, Serbia)D. Orlic (Belgrade, Serbia)M.M. Ostojic (Belgrade, Serbia)B. Parapid (Belgrade, Serbia)M. Pavlovic (Nis, Serbia)S. Pavlovic (Belgrade, Serbia)Z. Perisic (Nis, Serbia)J. Perunicic (Belgrade, Serbia)M. Petrovic (Belgrade, Serbia)M. Ristic (Belgrade, Serbia)A. Ristic (Belgrade, Serbia)S. Rusovic (Belgrade, Serbia)D. Sagic (Belgrade, Serbia)P. Seferovic (Belgrade, Serbia)D. Simeunovic (Belgrade, Serbia)D. Simic (Belgrade, Serbia)R. Sindjelic (Belgrade, Serbia)G. Stankovic (Belgrade, Serbia)B. Stefanovic (Belgrade, Serbia)J. Stepanovic(Belgrade, Serbia)S. Stojkovic (Belgrade, Serbia)Z. Stajic (Belgrade, Serbia) Dj. Stojsic (Novi Sad, Serbia)M. Tomasevic (Belgrade, Serbia)D. Topic (Belgrade, Serbia)N. Tomic (S.Kamenica, Serbia)J. Saponjski (Belgrade, Serbia)V. Vukcevic (Belgrade, Serbia)B. Vujisic Tešic (Belgrade, Serbia)Z. Vasiljevic Pokrajcic (Belgrade, Serbia)V. Vucicevic (Belgrade, Serbia)M. Zivkovic (Belgrade, Serbia)

BELGRADE COURSE ON CLINICAL CARDIOPULMONARY EXERCISE TESTING

COURSE ORGANIZERSM. Ostojic (Belgrade, Serbia)I. Nedeljkovic (Belgrade, Serbia)S. Mazic (Belgrade, Serbia)A. Mezzani (Veruno, Italy)L. Vanhees (Leuven, Belgium)

SCIENTIFIC CO-ORGANIZERSB. Vujisic-Tesic (Belgrade, Serbia)J. Stepanovic (Belgrade, Serbia)C. Passino (Pisa, Italy)M. Sandri (Leipzig, Germany)A. Djordjevic-Dikic (Belgrade, Serbia)M. Petrovic (Belgrade, Serbia)V. Giga (Belgrade, Serbia)

SECRETARIESM. Dobric (Belgrade, Serbia)M. Banovic (Belgrade, Serbia)O. Nedeljkovic (Belgrade, Serbia) NURSESK. Matejic (Belgrade, Serbia)O. Tomin (Belgrade, Serbia)D. Bacic (Belgrade, Serbia)S. Birac (Belgrade, Serbia)K. Radulovic (Belgrade, Serbia)

FOREIGN FACULTYA. Mezzani (Veruno, Italy)C. Passino (Pisa, Italy)M. Sandri (Leipzig, Germany)L. Vanhees (Leuven, Belgium)W. Wijns (Aalst, Belgium)

SERBIAN FACULTYB. Beleslin (Belgrade, Serbia)S. Damjanovic (Belgrade, Serbia)M. Deljanin-Ilic (N. Banja, Serbia)M. Dekleva (Belgrade, Serbia)N. Dikic (Belgrade, Serbia)S. Dimkovic (Belgrade, Serbia)D. Dincic (Belgrade, Serbia)A. Djordjevic-Dikic (Belgrade, Serbia)S. Djordjevic – Saranovic (Belgrade, Serbia)V. Giga (Belgrade, Serbia)B. Ivanovic (Belgrade, Serbia)D. Kalimanovski-Ostric (Belgrade, Serbia)S. Mazic (Belgrade, Serbia)P. Minic (Belgrade, Serbia)I. Nedeljkovic (Belgrade, Serbia)M. Nedeljkovic (Belgrade. Serbia)S. Obradovic (Belgrade, Serbia)M. Ostojic (Belgrade, Serbia)M. Petrovic (Belgrade, Serbia)N. Radivojevic (Belgrade, Serbia)A. Ristic (Belgrade, Serbia)J. Stepanovic (Belgrade, Serbia)J. Suzic (Belgrade, Serbia)B. Vujisic-Tesic (Belgrade, Serbia)M. Vukoja (S. Kamenica)M. Zdravkovic (Belgrade, Serbia)V. Zugic (Belgrade, Serbia)

14

STAFF: Involved in data acquisition and patients examinationDivision of Cardiology, Clinical Center of SerbiaHead: Miodrag C. Ostojic, MD, PhD, FESC, FACC

Clinical Center of SerbiaCEO: Djordje Bajec, MD, PhD

Cardiology Department I including Ward for Hypertension and Ward for acquired and congenital heart disease in adultsChief: Danica Matic, MD, PhDDimitra Kalimanovska-Оstric, MD, PhD, and associates

Cardiology Department II With Ward for Myocardial, Pericardial Diseases and Pulmonary Hypertension, and Ward for Heart FailureChief: Petar M. Seferovic, MD, PhD, FESC, FACC, and associates

Cardiology Department III With Ward for Arrhythmology and Clinical Cardiology, Ward for Invasive Electrophysiology and Ward for Intensive Care in Arrhythmology and CardiologyChief: Dragan Simic, MD, PhD, and associates

Urgent Cardiology DepartmentChief: Zorana Vasiljevic, MD, PhD, FESC, andassociates

Urgent MedicineHead: Jovan Perunicic, MD, PhD, and associates

Catheterization Laboratory StaffMiodrag C. Ostojic, MD, PhD, FESC, FACC, ChiefAleksandra Arandjelovic MD, PhD, FESCSrdjan Aleksandric, MDBranko Beleslin, MD, PhD, FESC Vladimir Dedovic, MDMiodrag Dikic, MDMilan Dobric, MDJelena Kostic, MDVladan Kovacevic, MDZlatko Mehmedbegovic, MDDejan Milasinovic, MDMilan A. Nedeljkovic, MD, PhD, FESC, FACCDejan Orlic, MD, FESCMladen Ostojic, MDGoran Stankovic, MD, PhD, FESC, FACCSinisa Stojkovic, MD, PhD, FESCMilorad Tesic, MDVladan Vukcevic, MDMiodrag Zivkovic, MD

Head NursesNada Josifovski, and associatesMilanka Lukic, and associatesHead X-ray technician:Dragan Brkic, and associates

Pericardiology TeamPetar M. Seferovic, MD, PhD, FESC, FACCArsen Ristic, MD, PhD, FESC, and associates

Cardiac Ultrasound TeamMarija Boricic-Kostic, MDMilan Petrovic, MD, PhD, FESCBosiljka Vujisic-Tesic, MD, PhD, FESC, ChiefDanijela Zamaklar-Trifunovic, MDOlga Petrovic, MDOlga Nedeljkovic, MD

Laboratory for Cardiopulmonary Exercise TestingIvana Nedeljkovic, MD, PhD, FESC, ChiefDejana Popovic, MDMarko Banovic, MDKatarina Matejic, Head Nurse

Non-invasive Functional TestingJelena Stepanovic, MD, PhD, FESC, ChiefAna Djordjevic-Dikic, MD, PhD, FESC, ChiefVojislav Giga, MDIvana Paunovic, MDJelena Kostic, MD

Pace-maker Center “Prof.dr Milan-Bane Djordjevic”Goran Milasinovic, MD, PhD, FESC, Chief , and associates

Cardiac SurgeryMile Vranes, MD, PhD, HeadPetar Djukic, MD, PhD Miljko Ristic, MD, PhDDušan Velimirovic, MD, PhD, and associates

Vascular SurgeryLazar Davidovic, MD, PhD, Headand associatesVascular Ultrasound:Dragan Vasic, MD, and associates

AnaestesiologyRadomir Sindjelic, MD, PhD, Headand associatesAnaestesiology Policlinic:Vera Vucicevic, MDBiljana Milicic, MDEdina Niksic, MD

Institute for Nuclear Medicine, Clinical Center of SerbiaVladimir Obradovic, MD, PhD, HeadSmiljana Pavlovic, MD, PhDDragana Sobic-Saranovic, MD, PhDNebojsa Kozarevic, MDIsidora Grozdic, MD

15

UNDER THE AUSPICES OF

TRH Crown Prince Alexander and Princess Katherine KaradjordjevicMinistry of Health of the Republic of SerbiaMinistry of Science and Technological Development of the Republic of Serbia

ORGANIZED BY

Serbian Heart Foundation, in collaboration with:

Division of Cardiology, Clinical Center of Serbia, Belgrade, SerbiaCardiology Society of SerbiaWorking Group on Interventional Cardiology of Cardiology Society of SerbiaInstitute for cardiovascular diseases “Dedinje“, Belgrade, SerbiaMilitary medical academy, Belgrade, SerbiaClinical hospital center “Bezanijska kosa“, Belgrade, SerbiaClinical hospital center “Zvezdara“, Belgrade, SerbiaHospital center “Valjevo“, Valjevo, SerbiaCardiovascular nursing society of Serbia

ENDORSEMENT

Scientific programme endorsed by the European Association for Percutaneous Coronary Interventions (EAPCI), a registered branch of the European Society of Cardiology

School of Medicine, University of Belgrade

Vladimir Kanjuh, MD, PhD, Academician, Serbian Academy of Sciences and ArtsPresident of the Board of Cardiovascular Pathology of the Serbian Academy of Sciences and Arts

Vladimir Bumbasirevic, MD, PhD, Academician, Serbian Academy of Sciences and ArtsDean, University of Belgrade, School of Medicine

Predrag Pesko, MD, PhD, Member of Serbian Academy of Sciences and ArtsVice-Dean, Center for Continuous Medical Education, University of Belgrade, School of Medicine

Nebojsa Lalic, MD, PhD, Member of Serbian Academy of Sciences and ArtsVice-Dean, Center for International Collaboration University of Belgrade, School of Medicine

Dragan Micic, MD, PhD, Member of Serbian Academy of Sciences and ArtsVice-Dean for Undergraduate studies, University of Belgrade, School of Medicine

CLINICAL CENTER OF SERBIADjordje Bajec, MD, PhD, CEO

Policlinic: Sinisa Pavlovic, MD, PhD, DirectorPoliclinic: Zorica Miloševic, Head NurseCentral Pharmacy: Vesna Ciganovic, MrPh, Director

16

ORGANIZERSSerbian Heart Foundation, with collaboration of:

Division of Cardiology, Clinical Center of Serbia, Belgrade, SerbiaCardiology Society of SerbiaWorking Group on Interventional Cardiology of Cardiology Society of SerbiaInstitute for cardiovascular diseases “Dedinje“, Belgrade, SerbiaMilitary medical academy, Belgrade, SerbiaClinical hospital center “Bezanijska kosa“, Belgrade, SerbiaClinical hospital center “Zvezdara“, Belgrade, SerbiaHospital center “Valjevo“, Valjevo, SerbiaCardiovascular nursing society of Serbia

ENDORSEDSchool of Medicine, University of Belgrade, SerbiaClinical Centre of SerbiaScientific programme endorsed by EAPCI, a registered branch of the European Society of Cardiology

VENUE/TECHNICAL ORGANIZERSLive transmission of procedures to Best Western Hotel «M»,****Bulevar oslobodjenja 56a, 11000 Belgrade, Serbia

TRAVEL AGENCYTP “Mladost turist“ A.D.Bulevar oslobodjenja 56a, 11000 Belgrade, Serbiaphone: +381 11 309 55 05 fax: +381 11 309 55 06e-mail: [email protected], www.hotel-m.com

CORRESPONDENCEDivision of cardiology, Clinical Center of SerbiaVisegradska 26, Belgrade 11000, Serbiaphone: +381 11 361 36 53 +381 11 632 90 55 fax: +381 11 362 90 56e-mail: mostojic2003@yahoo.comwww.serbianheartfoundation.orgwww.uksrb.org

LANGUAGE- English- Serbian (for “Update Cardiology 2011“ and “First Symposium of cardiovascular nursing society of Serbia “)

MINI SYMPOSIA/COURSES- Update cardiology 2011 - What is new on horizon?- Training courses on TAVI, bifurcations, FFR

SPONSORSGeneral sponsor: Cordis Johnson&JohnsonAbbott, Actavis, AstraZeneca, Bayer, Berlin Chemie, Bimed – Medtronic, Biotronik, Boehringr-Ingelheim, Bosnalijek, Cordis - Johnson&Johnson, ECO Trade – Terumo, Galenika, Hemofarm, Jugohemija, Krka, Merck, Novartis, Pfizer, PharmaSwiss, Richter Gedeon, Sanofi Aventis, Servier, St. Jude

17

REGISTRATION FEE 300 EUR

RSD account: RSD 275-220025996-70EUR account: RS35275000022002600349Societe Generale Yugoslav Bank,Bulevar Dr Zorana Djindjica 50a, Belgrade, SerbiaFor exhibitors - 200 EUR.; For nurses and technicians - 100 EUR(payment in RSD, according to the official RSD exchange rate of National Bank of Serbia)

Includes:- Badge- Congress bag with materials- Sandwitches, fruits, coffee- Gala dinner - Monday April 11 2011, 20h- Access to all sessions of BASICS+ Cardiopulmonary exercise testing: From basic physiological principles to application in clinical cardiology Update cardiology 2011: What is new on horizon? Training courses: TAVI, bifurcations, FFR- Access to exhibition

SECRETARIAT ON SITESecretariat and Registration Desk in Workshop Venue will be on duty from April 8-12, 2011.WORKING HOURS: April 8: 10.00 am - 03:00 pm April 9: 08.00 am - 05:00 pm April 10: 08.00 am - 05:00 pm April 11: 08.00 am - 05:00 pm April 12: 08.00 am - 12:00 pm

COFFEE AND REFRESHMENT Coffee and refreshments are organized in the Exhibition areaTECHNICAL EXHIBITION An exhibition of scientific and technical equipments is organized in the Workshop Venue.CERTIFICATE OF ATTENDANCE EBAC certificate of attendance will be given to all registered participants at the Secretariat Desk on April 12, 2011. National certificates will be issued after BASICS+TARGET AUDIENCE Interventional Cardiologists, Interventional Radiologists, Cardiologists in CCU, and other medical specialists interested in cardiology and interventional vascular medicine.

18

INFORMATION ON EBAC ACCREDITED PROGRAMMES

The learning objectives of the BASICS+ are:

- education of interventional cardiologists- to update physicians’ knowledge with the latest evidence-based concepts in interventional cardiology- to train interventionalists in treatment of difficult lessions’ subset

The targeted audience are interventional cardiologists /radiologists, as well as general cardiologists, internal medicine specialists and other physicians interested in

interventional cardiology and adjunctive treatment of patients undergoing interventional procedures.

The “7th Belgrade Summit of Interventional Cardiologists plus (BASICS+)” is accredited by the European Board of Accreditation in Cardiology (EBAC) for 25 credit hours of External CME credits.

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

In compliance with EBAC/ EACCME guidelines, all speakers/ chairpersons participating in this programme have disclosed potential conflicts of interest that might cause a bias in the presentations. The Organising Committee is responsible for ensuring that all potential conflicts of interest relevant to the programme are declared to the audience prior to the CME activities.

Symposium “Inovacija znanja 2011“ in Serbian, that is organized from April 10-11, 2011, is not included in EBAC accreditation. Only BASICS+ is accredited by EBAC.

INFORMACIJE O AKREDITACIJI KONGRESA KODZDRAVSTVENOG SAVETA SRBIJE

Odlukom Zdravstvenog saveta Srbije broj 153-02-575/2011-02, od 1.3.2011. godine, pod brojem A-1-450/11, BelgrAde Summit of Interventuional cardiologistS plus (BASICS+), akreditovan je kao domaći simpozijum prve kategorije.

Učešće na ovom kongresu bodovaće se na sledeći način:

1. broj bodova za predavače: 13 2. broj bodova za pasivno učešće: 7

19

room

“BE

LGRA

DE”

Trai

ning

cou

rse

onbi

furc

atio

n le

sion

s

Rece

ptio

n D

esk

room “AVALA”BASICS+

BelgrAde Summit ofInterventional CardiologistS

EXH

IBIT

ION

HAL

LMain Entrance

GRO

UN

D L

EVEL

LEVE

L -1

klub

“BES

T W

ESTE

RN”

Sim

pozi

jum

:“In

ovac

ija z

nanj

a 20

08”

20

BASICS+(pages 25-31 of the ‘Scienti�c programme’)

Cardiopulmonary exercise testing in focus

(pages 58-65 of the ‘Scienti�c programme’)


(pages 54-57 of the ‘Scienti�c programme’)

Symposium of cardiovascular nursing society of Serbia

(pages 41-43 of the ‘Naučni program’)

Symposium of cardiovascular nursing society of Serbia

(pages 44-48 of the ‘Naučni program’)


Training courses(page 22 of the ‘Scienti�c programme’)

Update cardiology 2011(pages 24-30 of the ‘Naučni program’)


Training courses(page 22 of the ‘Scienti�c programme’)

Update cardiology 2011(pages 31-36 of the ‘Naučni program’)


Friday, April 8

Tuesday, April 12

Monday, April 11

Sunday, April 10

Saturday, April 9

EVENT CALENDAR

21

Tim

eSa

turd

ay, A

pril

9Su

nday

, Apr

il 10

Mon

day,

Apr

il 11

Tues

day,

Apr

il 12

08:3

0-12

:00

Live

ses

sion

1 (p

age

25)

10:0

0-11

:30

durin

g LS

1Ex

pert

lect

ures

1 (p

age

26)

Opt

imal

repe

rfus

ion

ther

apy

in

STEM

I

08:0

0-12

:00

Live

ses

sion

3 (p

age

32)

09:0

0-09

:30

durin

g LS

3Ex

pert

lect

ures

5 (p

age

33)

Muc

h Ad

o A

bout

… S

tent

s

10:0

0-11

:00

durin

g LS

3Ex

pert

lect

ures

6 (p

age

34)

Nig

htm

are

in th

e ca

th la

b

11:3

0-12

:00

durin

g LS

5BA

SICS

+ sy

mpo

sium

(pag

e 35

)Lo

adin

g do

se o

f clo

pido

grel

in

patie

nts

with

STE

MI

Live

ses

sion

5 (p

age

41)

09:0

0-09

:45

durin

g LS

5Ex

pert

lect

ures

9 (p

age

42)

Inte

rven

tions

for t

he s

truc

tura

l he

art d

isea

se –

par

t 1

11:0

0-11

:45

durin

g LS

5Ex

pert

lect

ures

10

(pag

e 43

)Fu

ture

of i

nter

vent

iona

l car

diol

ogy

Live

ses

sion

7 (p

age

47)

10:0

0-10

:30

durin

g LS

7Ex

pert

lect

ures

12

(pag

e 48

)In

terv

entio

ns fo

r the

str

uctu

ral

hear

t dis

ease

– p

art 2

12:0

0-13

:00

12:0

0-12

:30

Ope

ning

cer

emon

y (p

age

27)

12:3

0-13

:00

Expe

rt le

ctur

es 2

(pag

e 27

)Re

tros

pect

ive

and

pers

pect

ives

of

inte

rven

tiona

l car

diol

ogy

12:0

0-13

:00

BASI

CS+

sym

posi

um (p

age

36)

Sten

t for

life

initi

ativ

e. P

rimar

y PC

I ne

twor

ks

BASI

CS+

sym

posi

um (p

age

44)

Mee

t the

exp

erts

at t

echn

olog

y up

date

Clos

ing

cere

mon

y (p

age

49)

13:0

0-14

:00

BASI

CS+

sym

posi

um (p

age

28)

Dec

ade

of d

rug

elut

ing

sten

ts13

:00-

13:4

5Ex

pert

lect

ures

7 (p

age

37)

Chro

nic

tota

l occ

lusi

ons

14:0

0-14

:30

BASI

CS+

lect

ure

(pag

e 38

)TA

VI

14:3

0-17

:30

Live

ses

sion

2 (p

age

29)

15:0

0-15

:45

durin

g LS

2Ex

pert

lect

ures

3 (p

age

30)

Hea

rt fa

ilure

and

pul

mon

ary

hype

rten

sion

16:3

0-17

:00

durin

g LS

2Ex

pert

lect

ures

4 (p

age

31)

Inte

rven

tions

in a

cute

cor

onar

y sy

ndro

mes

Live

ses

sion

4 (p

age

39)

16:3

0-18

:00

durin

g LS

4Ex

pert

lect

ures

8 (p

age

40)

Clin

ical

phy

siol

ogy.

Mic

rocl

imat

e in

the

cath

lab:

pr

essu

re, t

empe

ratu

re a

nd li

ght

Live

ses

sion

6 (p

age

45)

16:0

0-16

:45

durin

g LS

6Ex

pert

lect

ures

11

(pag

e 46

)Sp

ecia

l top

ics

in in

terv

entio

nal

card

iolo

gy

20:0

0G

ala

dinn

er

BASI

CS+

Scie

ntifi

c Pr

ogra

mm

e at

-a-g

lanc

e

22

Sunday, April 10, 2011 Room “Belgrade”

09:30-13:30Transcatheter aortic-valve implantation (TAVI) training courseSupproted by unrestricted educational grant from Bimed-MedtronicTherapy development manager for TAVI programme: E. Van Kemenade (Amsterdam, The Netherland)Course coordinator: B. Beleslin (Belgrade, Serbia)

14:00-18:00Training course on bifurcationsSupproted by unrestricted educational grant from Cordis Johnson&JohnsonCourse co-directors: G. Stankovic (Belgrade, Serbia), V. Vukcevic (Belgrade, Serbia)

Monday, April 11, 2011 Room “Belgrade”

10:00-12:00Training course on fractional flow reserve (FFR) measurementSupproted by unrestricted educational grant from St. JudeCourse co-directors: N. Jagic (Kragujevac, Serbia), B. Beleslin (Belgrade, Serbia)

13:00-15:00Training course on bifurcationsSupproted by unrestricted educational grant from Cordis Johnson&JohnsonCourse co-director: G. Stankovic (Belgrade, Serbia)

16:00-17:00Training course on fractional flow reserve (FFR) measurementSupproted by unrestricted educational grant from St. JudeCourse co-directors: N. Jagic (Kragujevac, Serbia), B. Beleslin (Belgrade, Serbia)

BASICS+ TRAINING COURSES

23

24

25

Saturday, April 9, 2011 room “AVALA“

08:30-12:00 LIVE SESSION 1

Chairpersons: F. Van de Werf (Leuven, Belgium), M. Ostojic (Belgrade, Serbia), L. Finci (Geneve, Switzerland)

Commentators: T. Konorza (Essen, Germany), M. Noc (Ljubljana, Slovenia), V. Kanic (Maribor, Slovenia), R. Jung (S. Kamenica, Serbia), N. Jagic (Kragujevac, Serbia)

Case 1 (G. Sianos, M.A. Nedeljkovic, Z. Mehmemdbegovic)Case 2 (A.G. Osiev, D. Orlic, V. Dedovic)Case 3 (A. Protopopov, V. Vukcevic, M. Zivkovic)Case 4 (A. Galassi, B. Beleslin, M. Tesic)Case 5 (G. SIanos, M.A. Nedeljkovic, M.M. Ostojic)

on-duty for STEMI patients: M. Noc

Factoids: M. Dikic (Belgrade, Serbia), V. Kovacevic (Belgrade, Serbia)

Satu

rday

, Apr

il 9

26

Satu

rday

, Apr

il 9


10:00-11:30EXPERT LECTURES 1during Live session 1

OPTIMAL REPERFUSION THERAPY IN STEMI

Chairpersons: F. Van de Werf (Leuven, Belgium), M. Ostojic (Belgrade, Serbia)

Optimal reperfusion therapy in STEMI F. Van de Werf (Leuven, Belgium)STREAM STUDY: performance of Serbia. Round table with Principal investigator F. Van de Werf Panel: M. Ostojic (Belgrade, Serbia), M. Pavlovic (Nis, Serbia), Z. Perisic (Nis, Serbia), M. Tomasevic (Belgrade, Serbia), N. Ivancevic (Belgrade, Serbia), S. Petrovic (Belgrade, Serbia), T. Rajkovic (Nis, Serbia), M. Krotin (Belgrade, Serbia), I. Ilic (Belgrade, Serbia), D. Jovic (Belgrade, Serbia), S. Hinic (Belgrade, Serbia)

10:00-10:20

10:20-11:30

27

Chairpersons: M. Ostojic (Belgrade, Serbia), HRH A. Karadjordjevic (Belgrade, Serbia), Z. Stankovic (Belgrade, Serbia), Z. Obradovic (Belgrade, Serbia), B. Djelic (Belgrade, Serbia), N. Karanovic (Belgrade, Serbia), S. Pajovic (Belgrade, Serbia), M.S. Nedeljkovic (Belgrade, Serbia), V. Bumbasirevic (Belgrade, Serbia), L. Finci (Geneve, Switzerland), V. Kanjuh (Belgrade, Serbia), B. Beleslin (Belgrade, Serbia), M.A. Nedeljkovic (Belgrade, Serbia), G. Stankovic (Belgrade, Serbia), S. Stojkovic (Belgrade, Serbia), V. Vukcevic (Belgrade, Serbia)

OPENING CEREMONY

IN MEMORIAM: S. Nedeljkovic, A. Doganov

EXPERT LECTURES 2

RETROSPECTIVE AND PERSPECTIVES OF INTERVENTIONAL CARDIOLOGY

Leaders and legends in percutaneous coronary interventions L. Finci (Geneve, Switzerland)The future of bioabsorbable magnesium stents T. Konorza (Essen, Germany)


12:00-13:00 OPENING CEREMONY - EXPERT LECTURES 2

12:00-12:30

12:30-13:00

Satu

rday

, Apr

il 9

12:30-12:45

12:45-13:00

28

13:00-14:00

Satu

rday

, Apr

il 9


BASICS+ SYMPOSIUM

Supported by unrestricted educational grant from Cordis Johnson&Johnson

THE DECADE OF DRUG-ELUTING STENTS: 2001-2011

Chairman: M. Ostojic (Belgrade, Serbia)

Drug eluting stents – The first decade M. Ostojic (Belgrade, Serbia)Drug eluting stents in diabetes R. Jung (Sremska kamenica, Serbia)Drug eluting stents in multivessel disease Lj. Mangovski (Belgrade, Serbia)Drug eluting stents in acute myocardial infarction Z. Perisic (Nis, Serbia)Drug eluting stents in chronic total occlusions S. Stojkovic (Belgrade, Serbia)Round Table discussion

13:00-13:05

13:05-13:15

13:15-13:25

13:25-13:35

13:35-13:45

13:45-14:00

29



Chairperson: L. Finci (Geneve, Switzerland)

Commentators: T. Konorza (Essen, Germany), D. Sagic (Belgrade, Serbia), Z. Perisic (Nis, Serbia), A. Ernst (Zagreb, Cratia), I. Ungi (Szeged, Hungary), M. Hamilos (Heraklion, Greece)

Case 6 (A.G. Osiev, M. Tomasevic, Z. Mehmedbegovic)Case 7 (A. Manginas, G. Stankovic, M. Tesic)Case 8 (G. Sianos, V. Vukcevic, M. Zivkovic)Case 9 (A. Galassi, M. Ostojic, V. Dedovic)

on-duty for STEMI patients: M. Noc

Factoids: M. Dikic (Belgrade, Serbia), D. Milasinovic (Belgrade, Serbia)

Satu

rday

, Apr

il 9

30

15:00-15:45

Satu

rday

, Apr

il 9


EXPERT LECTURES 3during Live session 2

HEART FAILURE AND PULMONARY HYPERTENSION

Chairperson: S. Konstantinides (Alexandroupolis, Greece)

Management of acute right heart failure in venous thromboembolism: State of the art 2011 S. Konstantinides (Alexandroupolis, Greece)New therapeutic concepts for heart failure V. Mitrovic (Bad Nauheim, Germany)Pulmonary hypertension in left heart disease: Incidence and potential new treatments A. Manginas (Athens, Greece)

15:00-15:15

15:15-15:30

15:30-15:45

31


16:30-17:00EXPERT LECTURES 4during Live session 2

INTERVENTIONS IN ACUTE CORONARY SYNDROMESChairperson: L. Finci (Geneve, Switzerland)

Urgent coronary angiography/PCI after resuscitated cardiac arrest M. Noc (Ljubljana, Slovenia)PCI of unprotected left main artery in patients with shock V. Kanic (Maribor, Slovenia)

16:30-16:45

16:45-17:00

Satu

rday

, Apr

il 9

32

08:00-12:00

Sund

ay, A

pril

10

Sunday, April 10, 2011 room “AVALA“

LIVE SESSION 3

Chairperson: W. Wijns (Aalst, Belgium)

Commentators: D. Zorman (Ljubljana, Slovenia), O. Goktekin (Eskisehir, Turkey), A. Manginas (Athens, Greece), A.G. Osiev (Novosibirsk, Russia), Z. Piroth (Budapest, Hungary)

Case 10 (G. Sianos, M. Ostojic, M.A. Nedeljkovic, S. Aleksandric)Case 11 (T. Konorza, D. Orlic, M. Dobric)Case 12 (A. Galassi, M. Dikic, M. Zivkovic)Case 13 (G. Sianos, S. Stojkovic, M. Dobric)Case 14 (A. Galassi, G. Stankovic, V. Kovacevic)Case 15 (F. Eberli, A. Arandjelovic, M.M. Ostojic)


33

Sund

ay, A

pril

11

09:00-09:30 EXPERT LECTURES 5during Live session 3

MUCH ADO ABOUT… STENTS

Chairpersons: B. Beleslin (Belgrade, Serbia), W. Wijns (Aalst, Belgium), I. Durand-Zaleski (Paris, France)

Device-based therapies: Where are we going? W. Wijns (Aalst, Belgium)Highlights in the economics of interventional cardiology I. Durand-Zaleski (Paris, France)Gender disparities and coronary artery disease: Women’s health in 2011 B. Parapid (Belgrade, Serbia) Su

nday

, Apr

il 10


09:00-09:10

09:10-09:20

09:20-09:30

34

10:00-11:00

Sund

ay, A

pril

10



JOINT SESSION OF THE SERBIAN, TURKISH AND GREEK WORKING GROUP ON INTERVENTIONAL CARDIOLOGY

NIGHTMARE IN THE CATH LAB: COMPLICATION PRESENTATION SESSION

Chairpersons: M.A. Nedeljkovic (Belgrade, Serbia), O. Goktekin (Eskisehir, Turkey), A. Manginas (Athens, Greece)

Case presentation 1 M.A. Nedeljkovic (Belgrade, Serbia)Case presentation 2 R. Ozdemir (Malatya, Turkey)Case presentation 3 O. Goktekin (Eskisehir, Turkey)Case presentation 4 A. Manginas (Athens, Greece)Case presentation 5 D. Zorman (Ljubljana, Slovenia)Take home messages M.A. Nedeljkovic (Belgrade, Serbia)

10:00-10:10

10:10-10:20

10:20-10:30

10:30-10:40

10:40-10:50

10:50-11:00

35

Sund

ay, A

pril

11

11:30-12:00BASICS+ SYMPOSIUMduring Live session 3

Supported by unrestricted educational grant from Sanofi-Aventis

ANTIPLATELET THERAPY IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

Chairperson: M. Ostojic (Belgrade, Serbia), G. Patti (Rome, Italy)

ARMYDA family of studies: What have we learned about antiplatelet therapy? G. Patti (Rome, Italy)Loading dose of clopidogrel in patients with ST-elevation myocardial infarction M. Ostojic (Belgrade, Serbia)

Sund

ay, A

pril

10


11:30-11:45

11:45-12:00

36

12:00-13:00

Sund

ay, A

pril

10


BASICS+ SYMPOSIUM

Supported by unrestricted educational grant from AstraZeneca

STENT FOR LIFE INITIATIVE. PRIMARY PCI NETWORKS

Chairpersons: M. Ostojic (Belgrade, Serbia), W. Wijns (Aalst, Belgium), V. Nikolic Heitzler (Zagreb, Croatia)

Stent for life initiative in Serbia M. Ostojic (Belgrade, Serbia)Croatian primary PCI network: results, problems and advances V. Nikolic Heitzler (Zagreb, Croatia)Can we treat NSTEMI patients different then STEMI? The “KBC Zagreb” experience M. Strozzi (Zagreb, Croatia)ISACS - TC (International Survey of Acute Coronary Syndrome from Transitional Country) O. Manfrini (Bologna, Italy)

12:00-12:15

12:15-12:30

12:30-12:45

12:45-13:00

37

13:00-13:45 EXPERT LECTURES 7

CHRONIC TOTAL OCCLUSIONS

Chairpersons: G. Sianos (Thessaloniki, Greece), A. Galassi (Catania, Italy)

Retrograde techniques for CTO recanalisation G. Sianos (Thessaloniki, Greece)Step up - step down technique: from stiff to soft polymeric wires A. Galassi (Catania, Italy)Strategy after failed intervention in CTO patients cohort A. Protopopov (Krasnoyarsk, Russia) Su

nday

, Apr

il 11

Sund

ay, A

pril

10


13:00-13:15

13:15-13:30

13:30-13:45

38

14:00-14:30

Sund

ay, A

pril

10


BASICS+ LECTURE

TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)

Chairpersons: R. Bernat (K. Toplice, Croatia), G. Nikolic (Podgorica, Montenegro)

Starting the TAVI program - Croatian experience R. Bernat (K. Toplice, Croatia)Starting the TAVI program - Montenegro experience G. Nikolic (Podgorica, Montenegro)

14:00-14:15

14:15-14:30

39


Chairperson: W. Wijns (Aalst, Belgium)

Commentators: A. Protopopov (Krasnoyarsk, Russia), F. Eberli (Zurich, Switzerland), M. Strozzi (Zagreb, Croatia) R. Babic (Belgrade, Serbia), I. Ungi (Szeged, Hungary), S. Kedev (Skopje, FYR Macedonia)

Case 16 (G. Sianos, M.A. Nedeljkovic, M. Zivkovic)Case 17 (M. Bunc, S. Stojkovic, M.M. Ostojic)Case 18 (A. Ernst, M. Tomasevic, S. Aleksandric)Case 19 (A.G. Osiev, J. Kostic, V. Dedovic)Case 20 (D. Zorman, D. Orlic, M. Tesic)



Sund

ay, A

pril

11Su

nday

, Apr

il 10

40

16:30-18:00



Supported by unrestricted educational grant from St. Jude Medical

CLINICAL PHYSIOLOGY

MICROCLIMATE IN THE CATH LAB: PRESSURE, TEMPERATURE AND LIGHT

Chairpersons: W. Wijns (Aalst, Belgium), B. Beleslin (Belgrade, Serbia), N. Jagic (Kragujevac, Serbia)

Integrating Courage, Syntax and Fame W. Wijns (Aalst, Belgium)Influence of lesion morphology on the functional significance of coronary artery narrowings I. Ungi (Szeged, Hungary)The role of fractional flow reserve in acute coronary syndromes M. Hamilos (Heraklion, Greece)FFR economics data analysis - more expensive is cheaper N. Jagic (Kragujevac, Serbia)OCT - First experience in Serbia Z. Perisic (Nis, Serbia)Application of FFR measurement in everyday practice Z. Piroth (Budapest, Hungary)

16:30-16:45

16:45-17:00

17:00-17:15

17:15-17:30

17:30-17:45

17:45-18:00

Sund

ay, A

pril

10

41

Mon

day,

Apr

il 12

Mon

day,

Apr

il 11


Chairperson: M. Marzilli (Pisa, Italy)

Commmentators: L. Finci (Geneve, Switzerland), D. Zorman (Ljubljana, Slovenia), S. Rusovic (Belgrade, Serbia), Z. Piroth (Budapest, Hungary), F. Eberli (Zurich, Switzerland), S. Srdic (Banja Luka, RS, BiH)

Case 21 (G. Sianos, M. Ostojic, V. Vukcevic, Z. Mehmedbegovic)Case 22 (A. Galassi, J. Kostic, M. Tesic) Case 23 (G. Sianos, M.A. Nedeljkovic, M.M. Ostojic)Case 24 (A. Protopopov, D. Orlic, V. Dedovic)Case 25 (S. Kedev, V. Vukcevic, M. Tesic)

Simultaneous live case from Institute for cardiovascular diseases “Dedinje”


Monday, April 11, 2011 room “AVALA“

42

09:00-09:45

Mon

day,

Apr

il 11



INTERVENTIONS FOR THE STRUCTURAL HEART DISEASE – part 1

Chairpersons: I. Daehnert (Leipzig, Germany), A.G. Osiev (Novosibirsk , Russia)

Percutaneous pulmonary valve implantation in congenital heart disease I. Daehnert (Leipzig, Germany)Transcatheter interventions in patients with post infarction ventricular defects A.G. Osiev (Novosibirsk , Russia)Percutaneus aortic program: Ljubljana experiences M. Bunc (Ljubljana, Slovenia)

09:00-09:15

09:15-09:30

09:30-09:45

43

Mon

day,

Apr

il 12

Mon

day,

Apr

il 11

11:00-11:45 EXPERT LECTURES 10during Live session 5

FUTURE OF INTERVENTIONAL CARDIOLOGY

Chairperson: M. Marzilli (Pisa, Italy), W. Wijns (Aalst, Belgium), F. Eberli (Zurich, Switzerland)

Ischemia-reperfusion injury: Diagnosis and prevention M. Marzilli (Pisa, Italy)Regenerative medicine for the heart W. Wijns (Aalst, Belgium)Percutaneous revascularization – where are the limits? F. Eberli (Zurich, Switzerland)


11:00-11:15

11:15-11:30

11:30-11:45

44

12:00-13:00

Mon

day,

Apr

il 11


BASICS+ SYMPOSIUM

Supported by unrestricted educational grant from Abbott

MEET THE EXPERTS AT TECHNOLOGY UPDATE

Clinical update-Xience safety and efficacy Lj. Mangovski (Belgrade, Serbia)European bifurcation club perspective on dedicated stents G. Stankovic (Belgrade, Serbia)Polimers and beyond K. Stambuk (Zagreb, Croatia)Chronic total occlusions - new solutions G. Sianos (Thessaloniki, Greece)Complex cases and the right tools S. Stojkovic (Belgrade, Serbia)

12:00-12:12

12:12-12:24

12:24-12:36

12:36-12:48

12:48-13:00

45

Mon

day,

Apr

il 12

Mon

day,

Apr

il 11



Commentators: K. Stambuk (Zagreb, Croatia), S. Kedev (Skopje, FYR Macedonia), Lj. Mangovski (Belgrade, Serbia), M. Bunc (Ljubljana, Slovenia), N. Dobrijevic (Banja Luka, RS, BiH)

Case 26 (I. Daehnert, M. Djukic, V. Kovacevic)Case 27 (G. Sianos, M. Dikic, V. Dedovic)Case 28 (D. Redkin, A. Biryukov, S. Stojkovic, M. Tesic)Case 29 (A. Protopopov, A. Arandjelovic, M. Zivkovic)Case 29 (I. Daehnert, M. Djukic, V. Kovacevic)

Simultaneous live case from Clinical hospital center ‘Bezanijska Kosa’ (E. Merkulov)



46

16:00-16:45

Mon

day,

Apr

il 11



SPECIAL TOPICS IN INTERVENTIONAL CARDIOLOGY


DES in symptomatic myocardial bridging A. Ernst (Zagreb, Croatia)Routine radial and ulnar artery access in complex coronary interventions: tips and tricks S. Kedev (Skopje, FYR Macedonia)Polymer design rationale - functionality and biocompatibility K. Stambuk (Zagreb, Croatia)

16:00-16:45

16:15-16:30

16:30-16:45

47


Chairperson: M. Ostojic (Belgrade, Serbia)

Commentators: L. Finci (Geneva, Switzerland), S. Stojkovic (Belgrade, Serbia), B. Beleslin (Belgrade, Serbia), M.A. Nedeljkovic (Belgrade, Serbia), G. Stankovic (Belgrade, Serbia), V. Vukcevic (Belgrade, Serbia), J. Saponjski (Belgrade, Serbia)

Simultaneous live case from Military medical academy(EVAR procedure)Live case from Clinical hospital center “Zvezdara”Live case from Health center “Valjevo”

Tuesday, April 12, 2011 room “AVALA“

Tues

day,

Apr

il 12

48

10:00-10:30

Tues

day,

Apr

il 12



INTERVENTIONS FOR THE STRUCTURAL HEART DISEASE – part 2

Chairpersons: B. Clapp (London, United Kingdom)

PFO closure – is there a role after CLOSURE 1 B. Clapp (London, United Kingdom)

10:00-10:20

49

Tues

day,

Apr

il 12

12:00 CLOSING CEREMONY

Chairperson: M. Ostojic (Belgrade, Serbia), L. Finci (Geneve, Switzerland), B. Beleslin (Belgrade, Serbia), M.A. Nedeljkovic (Belgrade, Serbia), G. Stankovic (Belgrade, Serbia), S. Stojkovic (Belgrade, Serbia), V. Vukcevic (Belgrade, Serbia)


BelgrAde Summit of

Interventional

CardiologistS

th7

April 8-122011


From basic physiological principles to application in clinical cardiology

52

Frid

ay, A

pril

8, ro

om A

VALA

Satu

rday

, Apr

il 9,

room

BW

clu

b14

:00-

14:1

5W

elco

me

and

‘CPE

T on

BA

SICS

+ 7’

ove

rvie

w (p

age

54)

09:3

0-10

:45

Clin

ical

app

licat

ion

of C

PET

(pag

e 58

)14

.15-

15.4

5Ro

und

tabl

e on

CPE

T in

Ser

bia:

Les

sons

lear

ned

so

far (

page

55)

10:4

5-11

:00

Coffe

e br

eak

15:4

5-16

:00

Coffe

e br

eak

11:0

0-12

:00

Prac

tica

l lab

orat

ory

sess

ions

116

.00-

17.4

5Ph

ysio

logi

cal B

asis

of C

PET

(pag

e 56

)12

:00-

13:0

0CP

ET in

reha

bilit

atio

n (p

age

60)

17:4

5-18

:00

Coffe

e br

eak

13:0

0-14

:00

Prac

tica

l Lab

orat

ory

sess

ions

218

:00-

19:0

0CP

ET in

Spo

rt C

ardi

olog

y (p

age

57)

14:0

0-15

:00

Lunc

h br

eak

15:0

0-16

:00

CPET

in lu

ng d

esea

ses

and

in a

thle

tes

(pag

e 62

)16

:00-

17:0

0Pr

acti

cal l

abor

ator

y se

ssio

ns 3

17:0

0-17

-15

Coffe

e br

eak

17:1

5-18

:15

Roun

d ta

ble

on fr

uits

from

‘CPE

T fo

r BA

SICS

+ 7’

: Cur

rent

an

d fu

ture

join

t res

earc

h pr

ojec

ts (p

age

64)

18:1

5-18

:30

Conc

ludi

ng re

mar

ks a

nd c

erti

ficat

e aw

ard

(pag

e 65

)

Cardiopulmonary exercise testing in focusFrom basic physiological principles to application in clinical cardiology

Programme at a glance

53

54

14:00-14:15

Frid

ay, A

pril

8

Friday, April 8, 2011 room “AVALA“

WELCOME AND ‘CPET ON BASICS+ 7’ OVERVIEW

Organizers: I. Nedeljkovic (Belgrade, Serbia), S. Mazic (Belgrade, Serbia), A. Mezzani (Veruno, Italy), L. Vanhees (Leuven, Belgium)

Directors of the BASICS+ 2011: M. Ostojic (Belgrade, Serbia), W. Wijns (Aalst, Belgium)

55


14:15-15:45ROUND TABLE ON CPET IN SERBIA:LESSONS LEARNED SO FAR

Moderators: S. Dimkovic (Belgrade, Serbia), M.A. Nedeljkovic (Belgrade. Serbia), B. Ivanovic (Belgrade, Serbia)

Experience of the Division of cardiology, Clinical hospital center “Dr Dragisa Misovic” J. Suzic, S. Backovic, M. Kleut, M. Tadic, V. Celic (Belgrade, Serbia)Experience of the Divison of Cardiology, Clinical Center of Serbia V. Giga, D. Popovic, M. Banovic, I. Nedeljkovic (Belgrade, Serbia)Institute for pulmology, Sremska Kamenica M. Vukoja, M. Jovancevic- Drvenica, I. Kopitovic (S. Kamenica)Experience of the Division of cardiology, Clinical hospital center “Bezanijska Kosa” M. Zdravkovic, M. Krotin (Belgrade, Serbia)Experience of the Institute for mother and child health care of Serbia “DR VUKAN ČUPIĆ“ P. Minic (Belgrade, Serbia)Experience of the Institute „Niska Banja“ M. Deljanin-Ilic (N. Banja, Serbia)Serbian Institute of Sport S. Djordjevic – Saranovic, N. Antic, J. Zlatkovic, S. Mazic (Belgrade, Serbia)Discussion

Frid

ay, A

pril

814:15-14:25

14:25-14:35

14:35-14:45

14:45-14:55

14:55-15:05

15:05-15:20

15:20-15:30

15:30-15:45

56

16:00-17:45

Frid

ay, A

pril

8


PHYSIOLOGICAL BASIS OF CPET

Moderators: L. Vanhees (Leuven, Belgium), A. Mezzani (Veruno, Italy), S. Damjanovic (Belgrade, Serbia), B. Beleslin (Belgrade, Serbia)

What is physiology behind the measurement of oxygen consumption? S. Mazic (Belgrade, Serbia)CPET in clinical practice: Indications and protocols A. Djordjevic-Dikic (Belgrade, Serbia)General approach to conduction and interpretation of CPET C. Passino (Pisa, Italy)CPET for prognostic stratification in cardiovascular disease A. Mezzani (Veruno, Italy)Clinical use of new parameters offered by CPET L. Vanhees (Leuven, Belgium)Discussion

16:15-16:30

16:30-16:45

16:45-17:00

17:00-17:15

17:15-17:30

17:30-17:45

57


18:00-19:00 CPET IN SPORT CARDIOLOGY

Moderators: J. Stepanovic (Belgrade, Serbia), A. Djordjevic-Dikic (Belgrade, Serbia) Controversies of myocardial hypertrophy in sport J. Stepanovic (Belgrade, Serbia)ECG abnormalities are enough to close the case in sport cardiology? N. Dikic (Belgrade, Serbia)What have we learned from sport cardiology cases in Serbia- application of different diagnostic tools V. Giga (Belgrade, Serbia)Problem of syncope and palpitations in sport N. Radivojevic (Belgrade, Serbia)Discussion

Frid

ay, A

pril

8

18:00-18:10

18:10-18:20

18:20-18:30

18:30-18:40

18:40-19:00

58

09:30-11:00

Satu

rday

, Apr

il 9

Saturday, April 9, 2011 room BW club

CLINICAL APPLICATION OF CPET

Moderators: L. Vanhees (Leuven, Belgium), B. Vujisic-Tesic (Belgrade, Serbia), D. Kalimanovski-Ostric (Belgrade, Serbia), D. Dincic (Belgrade, Serbia), S. Obradovic (Belgrade, Serbia)

Pitfalls of ergospirometric systems: How can one control measurement validity? L. Vanhees (Leuven, Belgium)Influence of cardiovascular therapeutic interventions on parameters measured by CPET M. Ostojic (Belgrade, Serbia), W. Wijns (Aalst,Belgium), I. Nedeljkovic (Belgrade, Serbia), D. Trifunovic (Belgrade, Serbia)CPET for detection of myocardial ischemia: Additional role of imaging techniques I. Nedeljkovic (Belgrade, Serbia)CPET for assessment of diastolic dysfunction and diastolic heart failure M. Dekleva (Belgrade, Serbia)Discussion

09:30-09:45

09:45-10:00

10:00-10:15

10:15-10:30

10:30-11:00

59


11:00-12:00 PRACTICAL LABORATORY SESSIONS 1

Satu

rday

, Apr

il 9

Supported by Jaeger equipment

60

12:00-13:00

Satu

rday

, Apr

il 9


CPET IN REHABILITATION

Moderators: M. Sandri (Leipzig, Germany), C. Passino (Pisa, Italy), M Deljanin-Ilic (N, Banja, Serbia), I Nedeljkovic (Belgrade, Serbia)

CPET in preoperative risk evaluation A. Mezzani (Veruno, Italy)CPET for exercise prescription in cardiac rehabilitation M. Deljanin-Ilic (Niska Banja, Serbia)Ventilatory efficiency measured by CPET – A reasonable target in CHF training interventions M. Sandri (Leipzig, Germany)Discussion

12:00-12:15

12:15-12:30

12:30-12:45

12:45-13:00

61



Satu

rday

, Apr

il 9


62

15:00-16:00

Satu

rday

, Apr

il 9


CPET IN LUNG DESEASES AND IN ATHLETES

Moderators: P. Minic (Belgrade, Serbia), S. Mazic (Belgrade, Serbia), M. Petrovic (Belgrade, Serbia), V. Zugic (Belgrade, Serbia)

CPET in lung diseases V. Zugic (Belgrade, Serbia)CPET for evaluation of patients with pulmonary hypertension A. Ristic (Belgrade, Serbia)CPET in athlets S. Mazic (Belgrade, Serbia)Discussion

15:00-15:15

15:15-15:30

15:30-15:45

15:45-16:00

63



Satu

rday

, Apr

il 9


64

17:15-18:15

Satu

rday

, Apr

il 9


ROUND TABLE ON FRUITS FROM ‘CPET FOR BASICS+ 7’: CURRENT AND FUTURE JOINT RESEARCH PROJECTS

Moderators: M. Ostojic (Belgrade, Serbia), W. Wijns (Aalst, Belgium), A. Mezzani (Veruno, Italy), S. Mazic (Belgrade, Serbia), I. Nedeljkovic (Belgrade, Serbia)

65


18:15-18:30 CONCLUDING REMARKS AND CERTIFICATE AWARD

Satu

rday

, Apr

il 9

Moderators: M. Ostojic (Belgrade, Serbia), I. Nedeljkovic (Belgrade, Serbia), S. Mazic (Belgrade, Serbia), A. Mezzani (Veruno, Italy)

INDEX

AAleksandric S. 32, 39Antic N. 55Arandjelovic A. 32, 45 BBabic R. 39Backovic S. 55Banovic M. 55Beleslin B. 25, 27, 33, 40, 47, 49, 56 Bernat R. 37 Biryukov A. 45Bumbasirevic V. 27Bunc M. 39, 42CCelic V. 55Clapp B. 48 DDaehnert I. 42, 45Damjanovic S. 56Dedovic V. 25, 29, 39, 41, 45Dekleva M. 58Deljanin-Ilic M. 55, 60Dincic D. 58Djordjevic-Dikic A. 56, 57Djordjevic-Saranovic S. 55 Dikic M. 32, 45 Dikic N. 57Dimkovic S. 55Djelic B. 27 Djukic M. 45 Dobric M. 32 Dobrijevic N. 45Durand-Zaleski I. 33EEberli F. 32, 39, 41, 43Ernst A. 29, 39, 46 FFinci L. 25, 27, 29, 31, 41, 45, 46, 47, 49GGalassi A. 25, 29, 32, 37, 41 Giga V. 55, 57 Goktekin O. 32, 34HHamilos M. 29, 40 Hinic S. 26IIlic I. 26Ivancevic N. 26 Ivanovic B. 55 JJagic N. 25, 40Jovancevic-Drvenica M. 55Jovic D. 26

Jung R. 25, 28KKalimansovski-Ostric D. 58 Kanic V. 25, 31Kanjuh V. 27Karadjordjevic A. HRH 27 Karanovic N. 27Kedev S. 39, 41, 45, 46Kleut M. 55Konorza T. 25, 27, 29, 32 Konstantinides S. 30 Kopitovic I. 55 Kostic J. 39, 41Kovacevic V. 32, 45 Krotin M. 26, 55MManginas A. 29, 30, 32, 34 Mangovski Lj. 28, 44, 45 Manfrini O. 36 Marzilli M. 41, 43 Mazic S. 54, 55, 56, 62, 64, 65 Mehmedbegovic Z. 25, 29, 41Mezanni A. 54, 56, 64, 65Minic P. 55, 62 Mitrovic V. 30NNedeljkovic I. 54, 55, 58, 60, 64, 65Nedeljkovic M.A. 25, 27, 32, 34, 39, 41, 47, 49, 55Nedeljkovic M.S. 27Nikolic G. 37 Nikolic Heitzler V. 36Noc M. 25, 31OObradovic S. 58 Obradovic Z. 27 Orlic D. 25, 32, 39, 41Osiev A.G. 25, 29, 32, 39, 42 Ostojic M. 25, 26, 27, 28, 29, 32, 35, 36, 41, 47, 49, 54,58,64, 65Ostojic M.M. 25, 32, 39, 41 Ozdemir R. 34PPajovic S. 27Parapid B. 33Passino C. 56, 60Patti G. 35Pavlovic M. 26 Perisic Z. 26, 28, 29, 40 Petrovic M. 62Petrovic S. 26 Popovic D. 55Piroth Z. 32, 40, 41

Protopopov A. 25, 37, 39, 41, 45 RRadivojevic N. 57Rajkovic T. 26 Redkin D. 45Ristic A. 62 Rusovic S. 41 SSagic D. 29 Sandri M. 60 Saponjski J. 47 Sianos G. 25, 29, 32, 37, 39, 41, 44, 45 Srdic S. 41 Stambuk K. 44, 45, 46Stankovic G. 27, 29, 32, 44, 47, 49Stankovic Z. 27 Stepanovic J. 57 Stojkovic S. 27, 28, 32, 39, 44, 45, 47, 49Strozzi M. 36, 39 Suzic J. 55TTadic M. 55 Tesic M. 25, 29, 39, 41, 45Tomasevic M. 26, 29, 39 Trifunovic D. 58 UUngi I. 29, 39, 40VVahnees L. 54, 56, 58 Van de Werf F. 25, 26 Vujisic-Tesic B. 58Vukcevic V. 25, 27, 29, 41, 47, 49Vukoja M. 55 WWijns W. 32, 33, 36, 39, 40, 43, 54, 58, 64ZZivkovic M. 25, 29, 32, 39, 45Zdravkovic M. 55Zlatkovic J. 55 Zorman D. 32, 34, 39, 41Zugic V. 62

INDEX

ACTAVIS d.o.o.Đorđa Stanojevića 12, 11070 Novi Beograd

Tel: 011 / 20 99 300, Fax: 011 / 20 99 301

ACTAVIS d.o.o.Đorđa Stanojevića 12, 11070 Novi Beograd

Tel: 011 / 20 99 300, Fax: 011 / 20 99 301

Make the complex simple

Resolute IntegrityZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM

Introducing Resolute Integrity DES: designed to simplify your complex procedures. Resolute Integrity combines the clinical advantages of Resolute DES with the ground- breaking continuous sinusoid technology of Integrity BMS.

The result is a revolutionary new DES that provides superior deliverability1 and powerful clinical performance,2 making it even easier for you to address the needs of your complex cases. Find out more at www.medtronicstents.com

For distribution only in markets where Resolute Integrity DES is approved. Not for distribution in the USA or Japan. © 2010 Medtronic, Inc. All rights reserved. UC201103368EE 10/10

Resolute Integrity DES now has expanded indications for diabetes mellitus, multivessel disease, long lesions and small vessels. 1 Bench test data vs. Abbott Xience Prime and Boston Scienti�c Promus Element DES on �le at Medtronic, Inc. These tests are not indicative of clinical performance.2 RESOLUTE All Comers 12-month data. RESOLUTE All Comers evaluated the Resolute stent.

Make the complex simple

Resolute IntegrityZOTAROLIMUS-ELUTING CORONARY STENT SYSTEM

Introducing Resolute Integrity DES: designed to simplify your complex procedures. Resolute Integrity combines the clinical advantages of Resolute DES with the ground- breaking continuous sinusoid technology of Integrity BMS.

The result is a revolutionary new DES that provides superior deliverability1 and powerful clinical performance,2 making it even easier for you to address the needs of your complex cases. Find out more at www.medtronicstents.com

For distribution only in markets where Resolute Integrity DES is approved. Not for distribution in the USA or Japan. © 2010 Medtronic, Inc. All rights reserved. UC201103368EE 10/10

Resolute Integrity DES now has expanded indications for diabetes mellitus, multivessel disease, long lesions and small vessels. 1 Bench test data vs. Abbott Xience Prime and Boston Scienti�c Promus Element DES on �le at Medtronic, Inc. These tests are not indicative of clinical performance.2 RESOLUTE All Comers 12-month data. RESOLUTE All Comers evaluated the Resolute stent.

Act

ilyse

® ogl

as -

01

- 03

/201

1

Boehringer Ingelheim Serbia d.o.o. Beograd Milentija Popovića 5a, 11000 Beograd

Za kompletnu informaciju o leku dostupanSažetak karakteristika leka na zahtev, odobren aprila 2010.Actilyse® (alteplaza)Broj rešenja 982/2008/12 od 11.03.2008.

Samo za stručnu javnost

Kao distributer jedne od vode ih svetskih kompanija iz domena kardiologije, iji su

proizvodi neodvojivi deo angio sala širom sveta, sa ponosom predstavljamo novi stent sa lekom „Promus Element“ - stent nove generacije sa jedinstvenom platformom, još jedan u nizu proizvoda kompanije „Boston Scientic“ kojim želimo da na najkvalitetniji na in

pomognemo pacijentima u Srbiji.

Promus element

Proizvo a :

Documents

April 9-12 th 2011 7 · 3 Table of contents 1. Introductory word